Interestingly, some synthesized CPT analogues as drug for cancer treatment can improve efficacy independent of Top1 inhibition with novel mechanism of action by targeting important cancer survival-associated oncogenic proteins and/or by bypassing various treatment-resistant mechanisms28,29. The gene discussed is PROS1; the disease is cancer.